Nektar Therapeutics
NKTRHealthcare|Biotechnology|USA
$70.36
-2.55 (-3.50%)
Tangible Book
$19.55
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (442)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Zalevsky Jonathan | Chief R&D Officer | 2026-06-30 | SELL | 5,681 | $70 | $397.7K |
| ROBIN HOWARD W | President & CEO | 2026-06-17 | SELL | 20,000 | $60.75 | $1215K |
| Zalevsky Jonathan | Chief R&D Officer | 2026-06-15 | SELL | 5,538 | $60.71 | $336.2K |
| ROBIN HOWARD W | President & CEO | 2026-05-19 | SELL | 444 | $65.51 | $29.1K |
| Zalevsky Jonathan | Chief R&D Officer | 2026-05-19 | SELL | 199 | $65.51 | $13K |
| Zalevsky Jonathan | Chief R&D Officer | 2026-02-18 | SELL | 180 | $73 | $13.1K |
| ROBIN HOWARD W | President & CEO | 2026-02-18 | SELL | 423 | $73 | $30.9K |
| Zalevsky Jonathan | Chief R&D Officer | 2026-01-20 | SELL | 3,867 | $35.67 | $137.9K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-11-25 | SELL | 1,157 | $54.28 | $62.8K |
| Wilson Mark Andrew | Chief Legal Officer | 2025-11-25 | SELL | 630 | $54.28 | $34.2K |
| ROBIN HOWARD W | President & CEO | 2025-11-25 | SELL | 2,207 | $54.28 | $119.8K |
| ROBIN HOWARD W | President & CEO | 2025-09-09 | SELL | 6,666 | $46.69 | $311.2K |
| ROBIN HOWARD W | President & CEO | 2025-09-05 | SELL | 11,832 | $36.42 | $430.9K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-09-04 | SELL | 1,721 | $33.52 | $57.7K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-09-02 | SELL | 485 | $30.1 | $14.6K |
| ROBIN HOWARD W | President & CEO | 2025-09-02 | SELL | 1,500 | $30.16 | $45.2K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-08-19 | SELL | 725 | $26.59 | $19.3K |
| Wilson Mark Andrew | Chief Legal Officer | 2025-08-19 | SELL | 676 | $26.59 | $18K |
| ROBIN HOWARD W | President & CEO | 2025-08-19 | SELL | 1,573 | $26.59 | $41.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-05-19 | SELL | 714 | $10.05 | $7.2K |
| Wilson Mark Andrew | Chief Legal Officer | 2025-05-19 | SELL | 666 | $10.05 | $6.7K |
| ROBIN HOWARD W | President & CEO | 2025-05-19 | SELL | 1,547 | $10.05 | $15.5K |
| Zalevsky Jonathan | Chief R&D Officer | 2025-02-19 | SELL | 687 | $15.15 | $10.4K |
| Wilson Mark Andrew | Chief Legal Officer | 2025-02-19 | SELL | 736 | $15.15 | $11.2K |
| ROBIN HOWARD W | President & CEO | 2025-02-19 | SELL | 1,585 | $15.15 | $24K |
| Wilson Mark Andrew | Chief Legal Officer | 2024-12-24 | SELL | 3,331 | $13.5 | $45K |
| Zalevsky Jonathan | Chief R&D Officer | 2024-12-19 | SELL | 3,408 | $14.1 | $48K |
| ROBIN HOWARD W | President & CEO | 2024-12-18 | SELL | 8,802 | $15 | $132K |
| Zalevsky Jonathan | Chief R&D Officer | 2024-11-19 | SELL | 519 | $15.15 | $7.9K |
| Wilson Mark Andrew | Chief Legal Officer | 2024-11-19 | SELL | 427 | $15.15 | $6.5K |
| ROBIN HOWARD W | President & CEO | 2024-11-19 | SELL | 1,085 | $15.15 | $16.4K |
| Zalevsky Jonathan | Chief R&D Officer | 2024-08-19 | SELL | 458 | $19.2 | $8.8K |
| Wilson Mark Andrew | Chief Legal Officer | 2024-08-19 | SELL | 377 | $19.2 | $7.2K |
| ROBIN HOWARD W | President & CEO | 2024-08-19 | SELL | 992 | $19.2 | $19K |
| CHESS ROBERT | Director | 2024-06-14 | SELL | 1,300 | $18 | $23.4K |
| ROBIN HOWARD W | President & CEO | 2024-05-17 | SELL | 1,110 | $26.25 | $29.1K |
| Zalevsky Jonathan | Chief R&D Officer | 2024-05-17 | SELL | 490 | $26.25 | $12.9K |
| Wilson Mark Andrew | Chief Legal Officer | 2024-05-17 | SELL | 417 | $26.25 | $11K |
| Deep Track Biotechnology Master Fund, Ltd. | 10% Owner | 2024-05-10 | SELL | 3,733 | $26.7 | $99.7K |
| Zalevsky Jonathan | Chief R&D Officer | 2024-02-20 | SELL | 601 | $10.2 | $6.1K |
| Wilson Mark Andrew | Chief Legal Officer | 2024-02-20 | SELL | 507 | $10.2 | $5.2K |
| ROBIN HOWARD W | President & CEO | 2024-02-20 | SELL | 1,336 | $10.2 | $13.6K |
| ROBIN HOWARD W | President & CEO | 2023-11-17 | SELL | 1,325 | $7.35 | $9.7K |
| Zalevsky Jonathan | Chief R&D Officer | 2023-11-17 | SELL | 643 | $7.35 | $4.7K |
| Wilson Mark Andrew | Chief Legal Officer | 2023-11-17 | SELL | 479 | $7.35 | $3.5K |
| Curet Myriam | Director | 2023-09-18 | SELL | 291 | $10.35 | $3K |
| Ajer Jeffrey Robert | Director | 2023-09-18 | SELL | 291 | $10.35 | $3K |
| Zalevsky Jonathan | Chief R&D Officer | 2023-08-16 | SELL | 647 | $11.7 | $7.6K |
| Wilson Mark Andrew | Chief Legal Officer | 2023-08-16 | SELL | 481 | $11.7 | $5.6K |
| ROBIN HOWARD W | President & CEO | 2023-08-16 | SELL | 1,333 | $11.7 | $15.6K |
| Zalevsky Jonathan | Chief R&D Officer | 2023-05-16 | SELL | 653 | $10.8 | $7K |
| Wilson Mark Andrew | Chief Legal Officer | 2023-05-16 | SELL | 503 | $10.8 | $5.4K |
| ROBIN HOWARD W | President & CEO | 2023-05-16 | SELL | 1,357 | $10.8 | $14.7K |
| Zalevsky Jonathan | Chief R&D Officer | 2023-02-16 | SELL | 699 | $45 | $31.5K |
| Wilson Mark Andrew | Chief Legal Officer | 2023-02-16 | SELL | 552 | $45 | $24.8K |
| Thomsen Jillian B. | CFO | 2023-02-16 | SELL | 684 | $45 | $30.8K |
| ROBIN HOWARD W | President & CEO | 2023-02-16 | SELL | 1,309 | $45 | $58.9K |
| Zalevsky Jonathan | Chief R&D Officer | 2022-11-16 | SELL | 897 | $53.55 | $48.1K |
| Wilson Mark Andrew | Chief Legal Officer | 2022-11-16 | SELL | 579 | $53.55 | $31K |
| Thomsen Jillian B. | CFO | 2022-11-16 | SELL | 740 | $53.55 | $39.6K |
| ROBIN HOWARD W | President & CEO | 2022-11-16 | SELL | 2,534 | $53.55 | $135.7K |
| Curet Myriam | Director | 2022-09-23 | SELL | 280 | $47.4 | $13.3K |
| Ajer Jeffrey Robert | Director | 2022-09-23 | SELL | 280 | $47.4 | $13.3K |
| CHESS ROBERT | Director | 2022-09-22 | SELL | 340 | $47.85 | $16.3K |
| CHESS ROBERT | Director | 2022-09-22 | SELL | 680 | $10.05 | $6.8K |
| EASTHAM KARIN | Director | 2022-09-13 | SELL | 1,418 | $54.15 | $76.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2022-08-18 | SELL | 4,914 | $69.75 | $342.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2022-08-16 | SELL | 704 | $71.4 | $50.3K |
| Wilson Mark Andrew | SVP & General Counsel | 2022-08-16 | SELL | 213 | $71.4 | $15.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2022-08-16 | SELL | 134 | $71.4 | $9.5K |
| ROBIN HOWARD W | President & CEO | 2022-08-16 | SELL | 917 | $71.4 | $65.5K |
| Zalevsky Jonathan | Chief R&D Officer | 2022-05-16 | SELL | 1,445 | $59.25 | $85.6K |
| Wilson Mark Andrew | SVP & General Counsel | 2022-05-16 | SELL | 209 | $59.25 | $12.4K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2022-05-16 | SELL | 389 | $59.25 | $23.1K |
| ROBIN HOWARD W | President & CEO | 2022-05-16 | SELL | 2,435 | $59.25 | $144.3K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2022-05-16 | SELL | 306 | $59.25 | $18.1K |
| Labrucherie Gil M | SVP, COO & CFO | 2022-05-16 | SELL | 1,163 | $59.25 | $68.9K |
| Zalevsky Jonathan | Chief R&D Officer | 2022-02-16 | SELL | 727 | $164.25 | $119.5K |
| Wilson Mark Andrew | SVP & General Counsel | 2022-02-16 | SELL | 244 | $164.25 | $40.1K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2022-02-16 | SELL | 158 | $164.25 | $25.9K |
| ROBIN HOWARD W | President & CEO | 2022-02-16 | SELL | 832 | $164.25 | $136.7K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2022-02-16 | SELL | 323 | $164.25 | $53.1K |
| Labrucherie Gil M | SVP, COO & CFO | 2022-02-16 | SELL | 505 | $164.25 | $83K |
| Labrucherie Gil M | SVP, COO & CFO | 2021-11-18 | SELL | 1,610 | $196.5 | $316.4K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2021-11-16 | SELL | 449 | $197.4 | $88.7K |
| ROBIN HOWARD W | President & CEO | 2021-11-16 | SELL | 2,852 | $197.4 | $562.9K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2021-11-16 | SELL | 404 | $197.4 | $79.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2021-11-16 | SELL | 1,391 | $197.4 | $274.6K |
| Wilson Mark Andrew | SVP & General Counsel | 2021-11-16 | SELL | 438 | $197.4 | $86.4K |
| Curet Myriam | Director | 2021-09-22 | SELL | 244 | $266.7 | $65.2K |
| CHESS ROBERT | Director | 2021-09-22 | SELL | 307 | $269.1 | $82.5K |
| Ajer Jeffrey Robert | Director | 2021-09-22 | SELL | 244 | $266.7 | $65.2K |
| CHESS ROBERT | Director | 2021-09-09 | SELL | 1,219 | $240.15 | $292.6K |
| Labrucherie Gil M | SVP, COO & CFO | 2021-08-17 | SELL | 724 | $206.4 | $149.5K |
| Zalevsky Jonathan | Chief R&D Officer | 2021-08-16 | SELL | 511 | $207.45 | $106K |
| Wilson Mark Andrew | SVP & General Counsel | 2021-08-16 | SELL | 127 | $207.45 | $26.4K |
| ROBIN HOWARD W | President & CEO | 2021-08-16 | SELL | 768 | $207.45 | $159.3K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2021-08-16 | SELL | 889 | $207.45 | $184.5K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2021-08-16 | SELL | 413 | $207.45 | $85.6K |
| CHESS ROBERT | Director | 2021-07-22 | SELL | 381 | $252.15 | $96.2K |
| Zalevsky Jonathan | Chief R&D Officer | 2021-05-17 | SELL | 2,074 | $274.5 | $569.3K |
| Wilson Mark Andrew | SVP & General Counsel | 2021-05-17 | SELL | 128 | $274.5 | $35.1K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2021-05-17 | SELL | 893 | $274.5 | $245.1K |
| ROBIN HOWARD W | President & CEO | 2021-05-17 | SELL | 771 | $274.5 | $211.5K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2021-05-17 | SELL | 406 | $274.5 | $111.4K |
| Labrucherie Gil M | SVP, COO & CFO | 2021-05-17 | SELL | 527 | $274.5 | $144.5K |
| CHESS ROBERT | Director | 2021-04-14 | SELL | 533 | $284.7 | $151.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2021-02-16 | SELL | 1,609 | $335.55 | $540K |
| Wilson Mark Andrew | SVP & General Counsel | 2021-02-16 | SELL | 145 | $335.55 | $48.6K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2021-02-16 | SELL | 780 | $335.55 | $261.8K |
| ROBIN HOWARD W | President & CEO | 2021-02-16 | SELL | 766 | $335.55 | $257.1K |
| NORTHCOTT JOHN | SVP & Chief Commercial Officer | 2021-02-16 | SELL | 1,024 | $335.55 | $343.6K |
| Labrucherie Gil M | SVP, COO & CFO | 2021-02-16 | SELL | 532 | $335.55 | $178.4K |
| ROBIN HOWARD W | President & CEO | 2021-02-04 | SELL | 30,000 | $298.95 | $8968.5K |
| Labrucherie Gil M | SVP, COO & CFO | 2021-02-04 | SELL | 10,000 | $297.9 | $2979K |
| Wilson Mark Andrew | SVP & General Counsel | 2021-02-03 | SELL | 356 | $291.75 | $103.9K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2021-01-28 | SELL | 5,000 | $279.3 | $1396.5K |
| Myriam Curet | Director | 2020-12-15 | SELL | 104 | $267.3 | $27.8K |
| Zalevsky Jonathan | Chief R&D Officer | 2020-11-23 | SELL | 1,092 | $246 | $268.6K |
| Zalevsky Jonathan | Chief R&D Officer | 2020-11-16 | SELL | 1,975 | $253.95 | $501.4K |
| Wilson Mark Andrew | SVP & General Counsel | 2020-11-16 | SELL | 103 | $253.95 | $26.1K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2020-11-16 | SELL | 798 | $253.95 | $202.8K |
| ROBIN HOWARD W | President & CEO | 2020-11-16 | SELL | 798 | $253.95 | $202.7K |
| Labrucherie Gil M | SVP, COO & CFO | 2020-11-16 | SELL | 552 | $253.95 | $140.1K |
| Ajer Jeffrey Robert | Director | 2020-09-28 | SELL | 217 | $258.75 | $56.1K |
| CHESS ROBERT | Director | 2020-09-25 | SELL | 367 | $266.25 | $97.6K |
| Ajer Jeffrey Robert | Director | 2020-09-21 | SELL | 150 | $296.1 | $44.4K |
| Labrucherie Gil M | SVP, COO & CFO | 2020-09-17 | SELL | 133 | $299.4 | $39.9K |
| CHESS ROBERT | Director | 2020-09-08 | SELL | 533 | $277.95 | $148.2K |
| Labrucherie Gil M | SVP, COO & CFO | 2020-08-18 | SELL | 550 | $295.05 | $162.2K |
| Zalevsky Jonathan | Chief R&D Officer | 2020-08-17 | SELL | 1,747 | $295.05 | $515.4K |
| Wilson Mark Andrew | SVP & General Counsel | 2020-08-17 | SELL | 102 | $295.05 | $30.1K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2020-08-17 | SELL | 91 | $295.05 | $26.9K |
| ROBIN HOWARD W | President & CEO | 2020-08-17 | SELL | 792 | $295.05 | $233.8K |
| GREER R SCOTT | Director | 2020-07-09 | SELL | 1,001 | $375 | $375.2K |
| CHESS ROBERT | Director | 2020-07-08 | SELL | 533 | $368.7 | $196.6K |
| Labrucherie Gil M | SVP, COO & CFO | 2020-05-19 | SELL | 515 | $338.1 | $174.2K |
| Zalevsky Jonathan | Chief R&D Officer | 2020-05-18 | SELL | 304 | $337.65 | $102.6K |
| Wilson Mark Andrew | SVP & General Counsel | 2020-05-18 | SELL | 102 | $337.65 | $34.4K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2020-05-18 | SELL | 91 | $337.65 | $30.8K |
| ROBIN HOWARD W | President & CEO | 2020-05-18 | SELL | 598 | $337.65 | $201.9K |
| CHESS ROBERT | Director | 2020-04-15 | SELL | 533 | $275.7 | $147K |
| CHESS ROBERT | Director | 2020-03-11 | SELL | 533 | $251.85 | $134.3K |
| Zalevsky Jonathan | Chief R&D Officer | 2020-02-18 | SELL | 318 | $335.25 | $106.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2020-02-18 | SELL | 93 | $335.25 | $31.2K |
| ROBIN HOWARD W | President & CEO | 2020-02-18 | SELL | 563 | $335.25 | $188.8K |
| Labrucherie Gil M | SVP, COO & CFO | 2020-02-18 | SELL | 396 | $335.25 | $132.7K |
| CHESS ROBERT | Director | 2020-02-12 | SELL | 533 | $352.5 | $188K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2020-02-06 | SELL | 2,500 | $341.7 | $854.3K |
| Zalevsky Jonathan | Chief R&D Officer | 2019-11-18 | SELL | 264 | $269.55 | $71.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2019-11-18 | SELL | 181 | $269.55 | $48.8K |
| ROBIN HOWARD W | President & CEO | 2019-11-18 | SELL | 904 | $269.55 | $243.6K |
| Labrucherie Gil M | SVP, COO & CFO | 2019-11-18 | SELL | 591 | $269.55 | $159.3K |
| Labrucherie Gil M | SVP, COO & CFO | 2019-11-13 | SELL | 1,667 | $296.85 | $494.8K |
| ROBIN HOWARD W | President & CEO | 2019-10-17 | SELL | 6,667 | $260.55 | $1737K |
| Labrucherie Gil M | SVP, COO & CFO | 2019-10-15 | SELL | 1,667 | $237.45 | $395.8K |
| Ajer Jeffrey Robert | Director | 2019-09-30 | SELL | 158 | $270.9 | $42.9K |
| Lingnau Lutz | Director | 2019-09-27 | SELL | 200 | $267.6 | $53.5K |
| CHESS ROBERT | Director | 2019-09-27 | SELL | 267 | $269.85 | $72K |
| Ajer Jeffrey Robert | Director | 2019-09-20 | SELL | 150 | $303.6 | $45.5K |
| Labrucherie Gil M | SVP & CFO | 2019-09-16 | SELL | 1,667 | $307.8 | $513K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2019-09-05 | BUY | 1,000 | $259.2 | $259.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2019-08-16 | SELL | 121 | $272.25 | $32.8K |
| ROBIN HOWARD W | President & CEO | 2019-08-16 | SELL | 837 | $272.25 | $227.8K |
| Nicholson John | SVP & COO | 2019-08-16 | SELL | 255 | $272.25 | $69.3K |
| Labrucherie Gil M | SVP & CFO | 2019-08-16 | SELL | 338 | $272.25 | $91.9K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2019-08-16 | SELL | 216 | $272.25 | $58.9K |
| Labrucherie Gil M | SVP & CFO | 2019-08-14 | SELL | 1,667 | $266.85 | $444.8K |
| ROBIN HOWARD W | President & CEO | 2019-07-25 | SELL | 6,667 | $469.35 | $3129K |
| Labrucherie Gil M | SVP & CFO | 2019-07-10 | SELL | 1,667 | $518.55 | $864.3K |
| Lingnau Lutz | Director | 2019-07-08 | SELL | 667 | $519.45 | $346.3K |
| Labrucherie Gil M | SVP & CFO | 2019-06-17 | SELL | 1,667 | $505.65 | $842.8K |
| ROBIN HOWARD W | President & CEO | 2019-05-23 | SELL | 6,667 | $495 | $3300K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2019-05-16 | SELL | 129 | $470.55 | $60.5K |
| ROBIN HOWARD W | President & CEO | 2019-05-16 | SELL | 892 | $470.55 | $419.8K |
| Nicholson John | SVP & COO | 2019-05-16 | SELL | 272 | $470.55 | $127.9K |
| Labrucherie Gil M | SVP & CFO | 2019-05-16 | SELL | 251 | $470.55 | $118.2K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2019-05-16 | SELL | 163 | $470.55 | $76.8K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2019-05-16 | SELL | 231 | $470.55 | $108.6K |
| ROBIN HOWARD W | President & CEO | 2019-02-21 | SELL | 7,259 | $632.85 | $4593.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2019-02-19 | SELL | 121 | $635.85 | $76.6K |
| Nicholson John | SVP & COO | 2019-02-19 | SELL | 255 | $635.85 | $162K |
| Labrucherie Gil M | SVP & CFO | 2019-02-19 | SELL | 239 | $635.85 | $152.3K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2019-02-19 | SELL | 159 | $635.85 | $101.1K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2019-02-19 | SELL | 221 | $635.85 | $140.3K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2019-02-04 | SELL | 1,075 | $632.4 | $679.6K |
| Nicholson John | SVP & COO | 2019-01-28 | SELL | 4,200 | $642.3 | $2697.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2018-11-16 | SELL | 268 | $573.75 | $153.6K |
| ROBIN HOWARD W | President & CEO | 2018-11-16 | SELL | 1,022 | $573.75 | $586.2K |
| Nicholson John | SVP & COO | 2018-11-16 | SELL | 399 | $573.75 | $228.8K |
| Labrucherie Gil M | SVP & CFO | 2018-11-16 | SELL | 434 | $573.75 | $249.2K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2018-11-16 | SELL | 313 | $573.75 | $179.5K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2018-11-16 | SELL | 302 | $573.75 | $173K |
| Lingnau Lutz | Director | 2018-09-20 | SELL | 600 | $854.7 | $512.8K |
| Ajer Jeffrey Robert | Director | 2018-09-20 | SELL | 450 | $851.4 | $383.1K |
| CHESS ROBERT | Director | 2018-09-19 | SELL | 300 | $852.15 | $255.6K |
| GREER R SCOTT | Director | 2018-09-04 | SELL | 667 | $1010.85 | $673.9K |
| WINGER DENNIS L | Director | 2018-08-21 | SELL | 2,000 | $899.4 | $1798.8K |
| WINGER DENNIS L | Director | 2018-08-14 | SELL | 2,283 | $909 | $2075.6K |
| ROBIN HOWARD W | President & CEO | 2018-06-27 | SELL | 8,667 | $742.8 | $6437.6K |
| WHITFIELD ROY A | Director | 2018-06-06 | BUY | 333 | $870.6 | $290.2K |
| GREER R SCOTT | Director | 2018-06-06 | SELL | 667 | $904.2 | $602.8K |
| CHESS ROBERT | Director | 2018-06-05 | SELL | 667 | $827.4 | $551.6K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2018-05-16 | SELL | 271 | $1250.85 | $338.6K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2018-05-16 | SELL | 229 | $1250.85 | $286.4K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2018-05-16 | SELL | 238 | $1250.85 | $298.2K |
| ROBIN HOWARD W | President & CEO | 2018-05-16 | SELL | 853 | $1250.85 | $1066.6K |
| Nicholson John | SVP & COO | 2018-05-16 | SELL | 328 | $1250.85 | $410K |
| Labrucherie Gil M | SVP & CFO | 2018-05-16 | SELL | 329 | $1250.85 | $412K |
| Labrucherie Gil M | SVP & CFO | 2018-05-03 | SELL | 6,000 | $1260.75 | $7564.5K |
| ROBIN HOWARD W | President & CEO | 2018-05-03 | SELL | 8,667 | $1260.75 | $10926.5K |
| CHESS ROBERT | Director | 2018-05-03 | SELL | 1,667 | $1242 | $2070K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2018-04-16 | SELL | 925 | $1521.9 | $1408.4K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2018-04-10 | SELL | 33 | $1585.05 | $53K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2018-04-09 | SELL | 1,967 | $1542.15 | $3032.7K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2018-04-09 | SELL | 10,667 | $1395.9 | $14889.6K |
| GREER R SCOTT | Director | 2018-04-06 | SELL | 2,000 | $1383.3 | $2766.6K |
| CHESS ROBERT | Director | 2018-04-06 | SELL | 1,667 | $1382.1 | $2303.5K |
| Lingnau Lutz | Director | 2018-04-05 | SELL | 2,000 | $1526.1 | $3052.2K |
| KUEBLER CHRISTOPHER A | Director | 2018-03-07 | SELL | 2,667 | $1464 | $3904K |
| Nicholson John | SVP & COO | 2018-03-07 | SELL | 14,676 | $1489.05 | $21853.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2018-02-16 | SELL | 170 | $1244.1 | $211.1K |
| ROBIN HOWARD W | President & CEO | 2018-02-16 | SELL | 853 | $1244.1 | $1060.6K |
| Nicholson John | SVP & COO | 2018-02-16 | SELL | 325 | $1244.1 | $404.7K |
| Labrucherie Gil M | SVP & CFO | 2018-02-16 | SELL | 232 | $1244.1 | $288.4K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2018-02-16 | SELL | 192 | $1244.1 | $238.5K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2018-02-16 | SELL | 162 | $1244.1 | $201.2K |
| ROBIN HOWARD W | President & CEO | 2018-01-22 | SELL | 5,556 | $1137.3 | $6318.3K |
| KUEBLER CHRISTOPHER A | Director | 2018-01-02 | SELL | 2,000 | $879.9 | $1759.8K |
| ROBIN HOWARD W | President & CEO | 2017-12-13 | SELL | 5,556 | $835.35 | $4640.8K |
| Nicholson John | SVP & COO | 2017-11-13 | SELL | 1,061 | $566.7 | $601.1K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-11-08 | SELL | 26,422 | $435 | $11493.4K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-11-06 | SELL | 341 | $376.05 | $128.3K |
| ROBIN HOWARD W | President & CEO | 2017-11-01 | SELL | 5,556 | $353.55 | $1964.2K |
| ROBIN HOWARD W | President & CEO | 2017-10-09 | SELL | 5,556 | $363 | $2016.7K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-10-05 | SELL | 506 | $375 | $189.6K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-10-05 | SELL | 2,912 | $374.55 | $1090.6K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-10-02 | SELL | 6,667 | $362.1 | $2414K |
| Labrucherie Gil M | SVP & CFO | 2017-10-02 | SELL | 8,000 | $366.75 | $2934K |
| Lingnau Lutz | Director | 2017-09-22 | SELL | 333 | $329.55 | $109.9K |
| KUEBLER CHRISTOPHER A | Director | 2017-09-22 | SELL | 267 | $327.9 | $87.4K |
| CHESS ROBERT | Director | 2017-09-21 | SELL | 427 | $325.8 | $139K |
| ROBIN HOWARD W | President & CEO | 2017-09-06 | SELL | 5,556 | $323.1 | $1795K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2017-08-16 | SELL | 177 | $289.8 | $51.2K |
| ROBIN HOWARD W | President & CEO | 2017-08-16 | SELL | 6,114 | $288.9 | $1766.4K |
| Nicholson John | SVP & COO | 2017-08-16 | SELL | 212 | $289.8 | $61.4K |
| Labrucherie Gil M | SVP & CFO | 2017-08-16 | SELL | 212 | $289.8 | $61.4K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-08-16 | SELL | 197 | $289.8 | $57.1K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-08-16 | SELL | 133 | $289.8 | $38.6K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-08-16 | SELL | 113 | $289.8 | $32.9K |
| WHITFIELD ROY A | Director | 2017-08-10 | BUY | 2,333 | $269.25 | $628.3K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-07-18 | SELL | 3,661 | $316.5 | $1158.8K |
| Lingnau Lutz | Director | 2017-07-14 | SELL | 2,000 | $311.4 | $622.8K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-07-12 | SELL | 3,005 | $316.2 | $950.3K |
| Nicholson John | SVP & COO | 2017-06-07 | SELL | 6,780 | $288.6 | $1956.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2017-05-16 | SELL | 177 | $293.25 | $51.8K |
| ROBIN HOWARD W | President & CEO | 2017-05-16 | SELL | 559 | $293.25 | $164K |
| Nicholson John | SVP & COO | 2017-05-16 | SELL | 210 | $293.25 | $61.5K |
| Labrucherie Gil M | SVP & CFO | 2017-05-16 | SELL | 212 | $293.25 | $62.1K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-05-16 | SELL | 197 | $293.25 | $57.8K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-05-16 | SELL | 97 | $293.25 | $28.3K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-05-16 | SELL | 113 | $293.25 | $33.3K |
| CHESS ROBERT | Director | 2017-05-15 | SELL | 333 | $296.85 | $99K |
| CHESS ROBERT | Director | 2017-04-17 | SELL | 333 | $280.8 | $93.6K |
| Lingnau Lutz | Director | 2017-04-07 | SELL | 467 | $300.75 | $140.4K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-04-05 | SELL | 6,667 | $325.5 | $2170K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-04-05 | SELL | 12,000 | $325.5 | $3906K |
| KUEBLER CHRISTOPHER A | Director | 2017-04-05 | SELL | 1,000 | $328.2 | $328.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2017-03-20 | SELL | 7,500 | $295.35 | $2215.1K |
| CHESS ROBERT | Director | 2017-03-14 | SELL | 333 | $231.15 | $77.1K |
| Labrucherie Gil M | SVP & CFO | 2017-03-03 | SELL | 13,333 | $227.4 | $3032K |
| Lingnau Lutz | Director | 2017-02-21 | SELL | 2,000 | $196.2 | $392.4K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2017-02-16 | SELL | 84 | $197.1 | $16.6K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2017-02-16 | SELL | 131 | $197.1 | $25.8K |
| ROBIN HOWARD W | President & CEO | 2017-02-16 | SELL | 576 | $197.1 | $113.5K |
| Nicholson John | SVP & COO | 2017-02-16 | SELL | 216 | $197.1 | $42.5K |
| Labrucherie Gil M | SVP & CFO | 2017-02-16 | SELL | 157 | $197.1 | $31K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2017-02-16 | SELL | 146 | $197.1 | $28.8K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2017-02-16 | SELL | 97 | $197.1 | $19.1K |
| ROBIN HOWARD W | President & CEO | 2017-02-08 | SELL | 5,833 | $195.6 | $1141K |
| Nicholson John | SVP & COO | 2017-02-03 | SELL | 5,000 | $185.85 | $929.3K |
| ROBIN HOWARD W | President & CEO | 2017-01-17 | SELL | 5,833 | $185.25 | $1080.6K |
| ROBIN HOWARD W | President & CEO | 2016-12-07 | SELL | 5,833 | $183.6 | $1071K |
| ROBIN HOWARD W | President & CEO | 2016-11-17 | SELL | 6,231 | $208.2 | $1297.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-11-16 | SELL | 132 | $209.4 | $27.7K |
| Nicholson John | SVP & COO | 2016-11-16 | SELL | 110 | $209.4 | $23.1K |
| Labrucherie Gil M | SVP & CFO | 2016-11-16 | SELL | 110 | $209.4 | $23.1K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2016-11-16 | SELL | 110 | $209.4 | $23.1K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2016-11-16 | SELL | 57 | $209.4 | $11.8K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2016-11-16 | SELL | 45 | $209.4 | $9.4K |
| GREER R SCOTT | Director | 2016-10-24 | BUY | 1,000 | $202.5 | $202.5K |
| ROBIN HOWARD W | President & CEO | 2016-10-04 | SELL | 5,833 | $255.9 | $1492.8K |
| KUEBLER CHRISTOPHER A | Director | 2016-09-16 | SELL | 500 | $286.95 | $143.5K |
| Lingnau Lutz | Director | 2016-09-15 | SELL | 600 | $285.9 | $171.5K |
| CHESS ROBERT | Director | 2016-09-15 | SELL | 800 | $288.15 | $230.5K |
| ROBIN HOWARD W | President & CEO | 2016-09-01 | SELL | 5,833 | $267.45 | $1560.1K |
| Nicholson John | SVP & COO | 2016-08-16 | SELL | 221 | $263.4 | $58.2K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-08-16 | SELL | 265 | $263.4 | $69.7K |
| ROBIN HOWARD W | President & CEO | 2016-08-16 | SELL | 788 | $263.4 | $207.5K |
| Labrucherie Gil M | SVP & CFO | 2016-08-16 | SELL | 220 | $263.4 | $58K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2016-08-16 | SELL | 220 | $263.4 | $58K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2016-08-16 | SELL | 112 | $263.4 | $29.6K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2016-08-16 | SELL | 89 | $263.4 | $23.5K |
| CHESS ROBERT | Director | 2016-08-01 | SELL | 333 | $258.9 | $86.3K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-07-11 | SELL | 6,667 | $226.35 | $1509K |
| CHESS ROBERT | Director | 2016-07-01 | SELL | 333 | $211.5 | $70.5K |
| CHESS ROBERT | Director | 2016-06-01 | SELL | 333 | $232.5 | $77.5K |
| Nicholson John | SVP & CFO | 2016-05-17 | SELL | 57 | $203.7 | $11.6K |
| ROBIN HOWARD W | President & CEO | 2016-05-17 | SELL | 145 | $203.7 | $29.5K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2016-05-17 | SELL | 23 | $203.7 | $4.6K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2016-05-17 | SELL | 29 | $203.7 | $5.9K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2016-05-17 | SELL | 56 | $203.7 | $11.3K |
| Labrucherie Gil M | SVP & General Counsel | 2016-05-17 | SELL | 56 | $203.7 | $11.4K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-05-17 | SELL | 48 | $203.7 | $9.8K |
| Lingnau Lutz | Director | 2016-04-25 | SELL | 1,000 | $244.05 | $244.1K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-03-09 | SELL | 1,000 | $176.85 | $176.9K |
| Gergel Ivan P. | SVP & Chief Medical Officer | 2016-02-17 | SELL | 37 | $178.8 | $6.6K |
| Nicholson John | SVP & CFO | 2016-02-17 | SELL | 64 | $178.8 | $11.5K |
| ROBIN HOWARD W | President & CEO | 2016-02-17 | SELL | 143 | $178.8 | $25.6K |
| Doberstein Stephen K | SVP & Chief Scientific Officer | 2016-02-17 | SELL | 26 | $178.8 | $4.6K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-02-17 | SELL | 48 | $178.8 | $8.5K |
| Labrucherie Gil M | SVP & General Counsel | 2016-02-17 | SELL | 55 | $178.8 | $9.9K |
| Hora Maninder | SVP Pharma Dev & Mfg Ops | 2016-02-17 | SELL | 64 | $178.8 | $11.5K |
| ROBIN HOWARD W | President & CEO | 2016-02-10 | SELL | 4,444 | $172.35 | $766K |
| Labrucherie Gil M | SVP & General Counsel | 2016-02-10 | SELL | 778 | $172.35 | $134K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-02-10 | SELL | 1,000 | $172.35 | $172.4K |
| Lingnau Lutz | Director | 2016-01-20 | SELL | 1,000 | $217.65 | $217.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2016-01-19 | SELL | 1,000 | $211.8 | $211.8K |
| ROBIN HOWARD W | President & CEO | 2016-01-19 | SELL | 4,444 | $211.8 | $941.3K |
| Labrucherie Gil M | SVP & General Counsel | 2016-01-19 | SELL | 778 | $211.8 | $164.7K |
| KUEBLER CHRISTOPHER A | Director | 2015-12-04 | SELL | 1,000 | $237.3 | $237.3K |
| Labrucherie Gil M | SVP & General Counsel | 2015-12-03 | SELL | 3,000 | $238.05 | $714.2K |
| ROBIN HOWARD W | President & CEO | 2015-12-03 | SELL | 8,333 | $238.05 | $1983.8K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2015-12-03 | SELL | 1,000 | $238.05 | $238.1K |
| WANG SUSAN | Director | 2015-11-20 | SELL | 5,667 | $225.3 | $1276.7K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2015-11-11 | SELL | 1,000 | $202.8 | $202.8K |
| ROBIN HOWARD W | President & CEO | 2015-11-11 | SELL | 8,333 | $202.8 | $1690K |
| Labrucherie Gil M | SVP & General Counsel | 2015-11-11 | SELL | 3,000 | $202.8 | $608.4K |
| Lingnau Lutz | Director | 2015-10-28 | SELL | 833 | $180 | $150K |
| ROBIN HOWARD W | President & CEO | 2015-10-06 | SELL | 8,333 | $164.85 | $1373.8K |
| Labrucherie Gil M | SVP & General Counsel | 2015-10-06 | SELL | 3,000 | $164.85 | $494.6K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2015-10-06 | SELL | 1,000 | $164.85 | $164.9K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2015-09-23 | SELL | 667 | $195.6 | $130.4K |
| ROBIN HOWARD W | President & CEO | 2015-09-23 | SELL | 8,333 | $195.6 | $1630K |
| Labrucherie Gil M | SVP & General Counsel | 2015-09-23 | SELL | 3,000 | $195.6 | $586.8K |
| Labrucherie Gil M | SVP & General Counsel | 2015-08-13 | SELL | 2,222 | $163.35 | $363K |
| ROBIN HOWARD W | President & CEO | 2015-08-13 | SELL | 3,889 | $163.35 | $635.2K |
| Nicholson John | SVP & CFO | 2015-08-12 | SELL | 21,326 | $161.7 | $3448.3K |
| ROBIN HOWARD W | President & CEO | 2015-07-14 | SELL | 3,889 | $176.7 | $687.2K |
| Labrucherie Gil M | SVP & General Counsel | 2015-07-14 | SELL | 2,222 | $176.7 | $392.7K |
| WANG SUSAN | Director | 2015-06-29 | SELL | 2,000 | $190.5 | $381K |
| CHESS ROBERT | Director | 2015-06-19 | SELL | 1,000 | $177.15 | $177.2K |
| Lingnau Lutz | Director | 2015-06-15 | SELL | 1,667 | $167.25 | $278.8K |
| KUEBLER CHRISTOPHER A | Director | 2015-01-13 | SELL | 1,000 | $240 | $240K |
| CHESS ROBERT | Director | 2014-12-29 | SELL | 1,967 | $230.1 | $452.5K |
| Thomsen Jillian B. | SVP & Chief Accounting Officer | 2014-12-22 | SELL | 333 | $233.4 | $77.8K |
| Labrucherie Gil M | SVP & General Counsel | 2014-12-01 | SELL | 8,000 | $255.3 | $2042.4K |
| ROBIN HOWARD W | President & CEO | 2014-12-01 | SELL | 23,333 | $255.15 | $5953.5K |
| ROBIN HOWARD W | President & CEO | 2014-11-25 | SELL | 40,000 | $228.75 | $9150K |
| Labrucherie Gil M | SVP & General Counsel | 2014-11-24 | SELL | 700 | $225.6 | $157.9K |
| Lingnau Lutz | Director | 2014-11-24 | SELL | 1,000 | $225.3 | $225.3K |
| Labrucherie Gil M | SVP & General Counsel | 2014-11-03 | SELL | 660 | $206.7 | $136.4K |
| WHITFIELD ROY A | Director | 2013-08-05 | SELL | 833 | $186.15 | $155.1K |
| KUEBLER CHRISTOPHER A | Director | 2013-08-05 | SELL | 833 | $186.15 | $155.1K |
| KUEBLER CHRISTOPHER A | Director | 2012-09-27 | SELL | 833 | $159.9 | $133.3K |
| WINGER DENNIS L | Director | 2012-09-14 | BUY | 333 | $137.7 | $45.9K |
| CHESS ROBERT | Director | 2012-07-13 | SELL | 1,600 | $127.5 | $204K |
| CHESS ROBERT | Director | 2011-03-08 | SELL | 300 | $135 | $40.5K |
| CHESS ROBERT | Director | 2010-05-10 | SELL | 2,333 | $209.25 | $488.3K |
| Labrucherie Gil M | SVP & General Counsel | 2009-05-12 | SELL | 26 | $83.55 | $2.2K |
| Thomsen Jillian B. | VP & Chief Accounting Officer | 2009-05-12 | SELL | 13 | $83.55 | $1.1K |
| Labrucherie Gil M | SVP & General Counsel | 2008-11-14 | SELL | 27 | $65.55 | $1.8K |
| Thomsen Jillian B. | VP & Chief Accounting Officer | 2008-11-14 | SELL | 14 | $65.55 | $0.9K |
| PATTON JOHN STUART | Chief Scientific Officer, Director | 2008-11-14 | SELL | 51 | $65.55 | $3.3K |
| CHESS ROBERT | Director | 2007-03-22 | SELL | 1,180 | $183.45 | $216.5K |
| ROBIN HOWARD W | President & CEO | 2007-03-05 | BUY | 667 | $169.05 | $112.7K |
| DRAPEAU LOUIS | Sr. VP Finance, CFO | 2007-03-05 | BUY | 67 | $176.55 | $11.8K |
| CHESS ROBERT | Chairman, Pres. & CEO | 2007-01-08 | SELL | 239 | $217.65 | $52.1K |
| DRAPEAU LOUIS | Sr. VP Finance, CFO | 2006-11-07 | BUY | 67 | $219.75 | $14.7K |
| DRAPEAU LOUIS | Sr. VP Finance, CFO | 2006-08-08 | BUY | 67 | $245.25 | $16.4K |
| PATTON JOHN STUART | Chief Scientific Officer | 2006-05-15 | SELL | 109 | $303.15 | $33K |
| DRAPEAU LOUIS | Sr. VP Finance, CFO | 2006-05-15 | BUY | 67 | $305.25 | $20.4K |
| GILL AJIT | Former Director, Pres. & CEO | 2006-03-23 | SELL | 236 | $294.15 | $69.5K |
| BANSAL AJAY | Former CFO | 2006-03-10 | SELL | 344 | $298.8 | $102.9K |
| CHESS ROBERT | Executive Chairman | 2006-03-07 | SELL | 147 | $297 | $43.8K |
| PATTON JOHN STUART | Chief Scientific Officer | 2006-03-07 | SELL | 257 | $297 | $76.4K |
| DRAPEAU LOUIS | Sr. VP Finance, CFO | 2006-03-03 | BUY | 67 | $301.2 | $20.1K |
| GILL AJIT | President & CEO | 2006-01-27 | SELL | 2,667 | $331.05 | $882.8K |
| PATTON JOHN STUART | Chief Scientific Officer | 2006-01-27 | SELL | 1,333 | $330 | $440K |
| PATTON JOHN STUART | Chief Scientific Officer | 2006-01-13 | SELL | 1,333 | $300.6 | $400.8K |
| GILL AJIT | President & CEO | 2005-09-09 | SELL | 2,000 | $317.55 | $635.1K |
| GILL AJIT | President & CEO | 2005-09-07 | SELL | 667 | $300.9 | $200.6K |
| BANSAL AJAY | CFO, VP Finance & Admin | 2005-09-07 | SELL | 200 | $299.4 | $59.9K |
| BANSAL AJAY | CFO, VP Finance & Admin | 2005-05-17 | SELL | 278 | $246.15 | $68.4K |
| PATTON JOHN STUART | Chief Scientific Officer | 2005-05-10 | SELL | 117 | $217.05 | $25.3K |
| PATTON JOHN STUART | Chief Scientific Officer | 2005-03-14 | SELL | 99 | $215.55 | $21.4K |
| BANSAL AJAY | CFO, VP Finance & Admin | 2005-01-03 | SELL | 467 | $300.9 | $140.4K |
| PATTON JOHN STUART | Chief Scientific Officer | 2004-12-15 | SELL | 227 | $291.3 | $66K |
| BANSAL AJAY | CFO, VP Finance & Admin | 2004-12-01 | SELL | 100 | $300 | $30K |
| CHESS ROBERT | Executive Chairman | 2004-03-08 | SELL | 3,773 | $340.35 | $1284.3K |
| CHESS ROBERT | Executive Chairman | 2004-03-05 | SELL | 6,667 | $328.05 | $2187K |
| GILL AJIT | President & CEO | 2004-03-05 | SELL | 1,453 | $360.9 | $524.5K |
| CHESS ROBERT | Executive Chairman | 2004-03-04 | SELL | 6,667 | $329.25 | $2195K |
| PATTON JOHN STUART | Chief Scientific Officer | 2004-03-04 | SELL | 1,333 | $332.7 | $443.6K |
| BANSAL AJAY | CFO, VP Finance & Admin | 2004-03-04 | SELL | 200 | $328.65 | $65.7K |
| HARRIS J MILTON | President of Nektar AL | 2004-03-04 | SELL | 6,667 | $325.95 | $2173K |
| GILL AJIT | President & CEO | 2004-03-04 | SELL | 3,333 | $329.55 | $1098.5K |
| HARRIS J MILTON | President of Nektar AL | 2004-03-02 | SELL | 2,397 | $295.5 | $708.5K |
| CHESS ROBERT | Executive Chairman | 2004-02-19 | SELL | 340 | $298.5 | $101.5K |
| HARRIS J MILTON | President of Nektar AL | 2004-02-19 | SELL | 5,998 | $295.95 | $1775K |
| HARRIS J MILTON | President of Nektar AL | 2004-02-18 | SELL | 2,116 | $297 | $628.5K |
| CHESS ROBERT | Executive Chairman | 2004-02-10 | SELL | 4,553 | $298.8 | $1360.5K |
| PATTON JOHN STUART | Chief Scientific Officer | 2004-02-10 | SELL | 1,333 | $300 | $400K |
| HARRIS J MILTON | President of Nektar AL | 2004-02-10 | SELL | 5,333 | $296.55 | $1581.6K |
| PATTON JOHN STUART | Chief Scientific Officer | 2004-01-13 | SELL | 1,333 | $272.85 | $363.8K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-09 | SELL | 708 | $254.1 | $179.9K |
| GILL AJIT | CEO & President | 2004-01-08 | SELL | 1,667 | $241.35 | $402.3K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-08 | SELL | 2,186 | $241.8 | $528.6K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-08 | SELL | 2,475 | $241.2 | $597K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-08 | SELL | 1,785 | $244.2 | $436K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-07 | SELL | 106 | $240 | $25.5K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-07 | SELL | 1,265 | $234.3 | $296.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-07 | SELL | 1,979 | $224.55 | $444.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-07 | SELL | 1,309 | $234.75 | $307.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-07 | SELL | 2,007 | $224.55 | $450.7K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-06 | SELL | 696 | $228.9 | $159.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-06 | SELL | 2,637 | $221.85 | $585K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-06 | SELL | 696 | $228.9 | $159.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-06 | SELL | 2,637 | $221.85 | $585K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-05 | SELL | 220 | $215.7 | $47.5K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-05 | SELL | 3,210 | $212.7 | $682.8K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-05 | SELL | 3,237 | $212.7 | $688.4K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-02 | SELL | 3,333 | $212.1 | $707K |
| HARRIS J MILTON | President Of Nektar AL | 2004-01-02 | SELL | 3,333 | $212.1 | $707K |
| HARRIS J MILTON | President of Nektar AL | 2003-12-31 | SELL | 487 | $212.1 | $103.3K |
| HARRIS J MILTON | President of Nektar AL | 2003-12-30 | SELL | 6,667 | $211.5 | $1410K |
| CHESS ROBERT | Executive Chairman | 2003-10-15 | SELL | 187 | $225 | $42K |
| HARRIS J MILTON | President of Nektar AL | 2003-10-15 | SELL | 3,333 | $225 | $750K |
| CHESS ROBERT | Executive Chairman | 2003-10-14 | SELL | 187 | $225 | $42K |
| HARRIS J MILTON | President of Nektar AL | 2003-10-14 | SELL | 253 | $225 | $57K |
| CHESS ROBERT | Executive Chairman | 2003-10-13 | SELL | 4,627 | $225.6 | $1043.8K |
| HARRIS J MILTON | President of Nektar AL | 2003-10-13 | SELL | 6,667 | $225 | $1500K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked